CTRI/2017/01/007712已完成不适用
Uptake of various forms and amounts of vitamin B12 (Part I-IMPROVIT)
Department of Biotechnology New Delhi India1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2015年10月21日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 61
- 试验地点
- 1
- 主要终点
- Difference in uptake
研究概览
简要总结
The rise in plasma holotranscobalamin is 2-3 folds higher in cyanocobalamin supplemented than hydroxocobalamin supplemented participants. Detail analysis is being carried out .
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Vegetarians with low plasma vitamin B12 in Indian participants and with normal vitamin B12 status Danish participants.
排除标准
- •Non vegetarians, cancer and the participants consuming vitamin B12 pills and the drugs known to influence vitamin B12 absorption.
结局指标
主要结局
Difference in uptake
时间窗: Baseline and two days after supplementation and then crossover
次要结局
- Metabolic effects of both cyano and hydroxo coabalamin in vegetarian Indians(Holotranscoabalamin levels before and after supplementation and crossover)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
1 期
Improving vitamin B12 status of Indians.CTRI/2019/08/021001BBSRC
已完成
不适用
TRIM: Danish Form and Dose Study on Vitamin B12HealthyNCT02832726University of Aarhus45
已完成
不适用
Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 AbsorptionVitamin B12 AbsorptionNCT00306358University of Aarhus78
已完成
不适用
Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With MetforminDiabetes Mellitus Type 2NCT02111967University Hospital, Basel, Switzerland50
已完成
4 期
Megadose of Hydroxocobalamin for the Treatment of Pernicious AnemiaMegaloblastic Anemia NosPernicious AnemiaNCT03372447Hospital Universitario Dr. Jose E. Gonzalez13